← SynDRA
CGP-12177
SynDRA canonical compound SYN0003108 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ADRB3 |
|---|
| Mechanism of action | Adrenergic receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor agonist
- ADRB1 PARTIAL AGONIST
- ADRB1 ANTAGONIST
- ADRB2 PARTIAL AGONIST
- ADRB2 ANTAGONIST
- ADRB3 PARTIAL AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADGRF1
- HDAC6
- UNG
- TDG
- SMUG1
- SAMHD1
- S1PR1
- PTH1R
- OGG1
- NTHL1
- NEIL2
- NEIL1
- MPG
- MBD4
- LMNA
- GPR35
- ADRA2A
- GPR119
- GLP1R
- FPR2
- FFAR4
- FEN1
- EHMT2
- DRD1
- CX3CR1
- C5AR1
- ATAD5
- ARSA
- APLNR
- AGTR1
- USP1
Cross-references
Synonyms
- Tbhpbo
- R89UMZ82MJ
- CHEBI:73288
- Cgp 12177A
- RefChem:912112
- 4-(3-tert-Butylamino-2-hydroxypropoxy)benzimidazol-2-one
- [3H]CGP 12177
- CGP12177A
- (+/-)-CGP-12177A hydrochloride
- UNII-R89UMZ82MJ
- [3H]CGP12177
- [3H]-CGP12177
- Spectrum_001907
- SpecPlus_000776
- Spectrum4_000777
- CGP-12177A hydrochloride
- Lopac0_000372
- GTPL532
- KBioGR_001194
- KBioSS_002444
- DivK1c_006872
- CGP 12177 (free base)
- GTPL5387
- SCHEMBL2016211
- BDBM25747
- KBio1_001816
- KBio2_002438
- KBio2_005006
- KBio2_007574
- CGP12177
- BDBM50027879
- CCG-204467
- SDCCGSBI-0050360.P003
- NCGC00015184-03
- NCGC00015184-04
- NCGC00015184-05
- NCGC00015184-08
- NCGC00025024-02
Look up CGP-12177 in the interactive SynDRA portal →